Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
about
Current Management of Primary Immune ThrombocytopeniaImmune thrombocytopeniaProspective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP).Adult idiopathic thrombocytopenic purpura.Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.Autoimmune thrombocytopenia.Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.Anti-RhD immunoglobulin in the treatment of immune thrombocytopeniaEfficacy and safety of anti-D for treatment of adults with immune thrombocytopenia.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Current treatment options for primary immune thrombocytopenia.ITP: a historical perspective.Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.Emerging drugs for immune thrombocytopenia (ITP).State of the art - how I manage immune thrombocytopenia.Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.Laparoscopic splenectomy: present status and future perspective.
P2860
Q26779408-A7DE92CB-2894-444E-93D6-3EDD53093F47Q26830918-68F58C37-1F08-440C-8A71-A1851DF2D753Q33349084-61BCCC6A-0D38-439E-8DB3-655E272D0DEAQ33358032-9A963613-5126-48C0-974A-CA4BC765D29EQ33359732-A46163C5-D85F-4D1D-BDEF-D5DAC9E3B66EQ33367505-37029728-2913-4BEF-85E5-B7E1336FE234Q33367861-8E4E4CCC-8C5A-4430-9270-A87F2ABE937FQ33369983-306287BC-7B38-432B-84D7-DBEB9DFC9AE2Q33374275-8989766B-E1D2-4B8C-AF45-24492B12D0D1Q33378585-32EE5282-1DB4-43E8-87DD-04586C3F3C16Q33385974-E03946D1-1D60-46D5-898E-5560FD8F57ABQ33386764-649FF102-6D72-46C9-A521-60B386E1447EQ33393732-4471F5B6-5FC9-4F4D-9CAB-8332880A0E5BQ33394149-6E7805FA-5339-4C96-9CE9-0EF2B2F2D500Q33394791-1FAB88AC-AFEC-4254-8875-C50DC9E1FE22Q33427336-8090DF0C-19B0-4B68-9951-3F1F277D2669Q33439789-8AF9D730-1DB2-46EA-991E-A2F98CCBF8F8Q33440145-8ED20E18-2E85-4E98-A2BF-B485323EC9FCQ33443173-03E98301-A4C3-4501-9799-A308490A3923Q36344086-A5CC9D0E-71FE-4770-86A4-53577981FA45
P2860
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Does treatment with intermitte ...... purpura to avoid splenectomy?
@ast
Does treatment with intermitte ...... purpura to avoid splenectomy?
@en
type
label
Does treatment with intermitte ...... purpura to avoid splenectomy?
@ast
Does treatment with intermitte ...... purpura to avoid splenectomy?
@en
prefLabel
Does treatment with intermitte ...... purpura to avoid splenectomy?
@ast
Does treatment with intermitte ...... purpura to avoid splenectomy?
@en
P2093
P356
P1433
P1476
Does treatment with intermitte ...... purpura to avoid splenectomy?
@en
P2093
B Michael R Woloski
Erin M Fodero
Juerg H Beer
Maria Novoa
Melissa Leber
Nichola Cooper
P304
P356
10.1182/BLOOD.V99.6.1922
P407
P577
2002-03-01T00:00:00Z